Clot risk to 18-39s from AstraZeneca vaccine is twice as high as Covid death risk, Euro study finds

The HSE has admitted a greater risk of blood clotting in younger people still exists for the AstraZeneca vaccine, but that risk is now outweighed by a need to speed up public vaccination. File picture

The HSE has admitted a greater risk of blood clotting in younger people still exists for the AstraZeneca vaccine, but that risk is now outweighed by a need to speed up public vaccination.

A new modelling study published in the European Centre for Disease Prevention and Control’s (ECDC) medical journal has concluded that the dangers presented to younger people by the AstraZeneca vaccine are greater than the benefits.